| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/11/2009 | EP1581526B1 Benzisoxazole derivatives useful as inhibitors of protein kinases |
| 03/11/2009 | EP1572689B1 Tetracyclic immunomodulatory compounds |
| 03/11/2009 | EP1567533B1 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |
| 03/11/2009 | EP1524981B1 Sustained release formulations comprising lamotrigine |
| 03/11/2009 | EP1519728B1 4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno(2,3-d) pyrimidine in the treatment of functional bowel disorder |
| 03/11/2009 | EP1516624B1 Method of producing calcium gluconolactate, compositions, processes and uses of same |
| 03/11/2009 | EP1499622B1 Heterotricyclyl 6-alkylidene-penems as beta-lactamase inhibitors |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1485096B1 Methods for preventing or treating cardiac arrhythmia |
| 03/11/2009 | EP1480984B9 Hexacyclic compounds |
| 03/11/2009 | EP1478229B1 Improved synthesis of polyanhyrides |
| 03/11/2009 | EP1471921B1 Counteracting bioprosthetic calcification |
| 03/11/2009 | EP1461050B1 Oral immunostimulation of mammals, birds, and reptiles from (1-4) linked beta-d-mannuronic acid |
| 03/11/2009 | EP1460992B1 Stabilized reverse micelle compositions and uses thereof |
| 03/11/2009 | EP1456182B1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i) |
| 03/11/2009 | EP1453519A4 Aqueous ifosfamide composition |
| 03/11/2009 | EP1435899B1 A composition for promoting hair growth |
| 03/11/2009 | EP1429845B1 Treatment or prophylaxis of insulin-producing cell graft rejection |
| 03/11/2009 | EP1411899B1 Taste masking composition |
| 03/11/2009 | EP1358165B1 Imidazole derivatives |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1326586B1 New pharmaceutical compositions containing epinastine and pseudoephedrine |
| 03/11/2009 | EP1319659B1 Triazinones and medicinal use thereof |
| 03/11/2009 | EP1318801B1 Topical analgesic compositions containing aliphatic polyamines and methods of using same |
| 03/11/2009 | EP1317445B1 Chemokine receptor binding heterocyclic compounds |
| 03/11/2009 | EP1301460B9 Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry |
| 03/11/2009 | EP1299081B9 Use of oligosaccharides to stimulate beta-endorphin production |
| 03/11/2009 | EP1294384B1 Use of lanthanum compounds for the treatment of bone diseases |
| 03/11/2009 | EP1185255B1 RETINOPROTECTIVE OPHTHALMOLOGIC MEDICINES comprising ramipril or ramiprilat |
| 03/11/2009 | EP1175399B1 Inhibitors of c-jun n-terminal kinases (jnk) |
| 03/11/2009 | EP1165564B1 Process for preparing inhibitors of nucleoside metabolism |
| 03/11/2009 | EP0976722B1 Benzamidine derivatives |
| 03/11/2009 | EP0847242B2 Sugar-free dragee-like products |
| 03/11/2009 | CN101384902A Compositions and methods related to controlled gene expression using viral vectors |
| 03/11/2009 | CN101384604A Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives |
| 03/11/2009 | CN101384603A Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 03/11/2009 | CN101384602A Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 03/11/2009 | CN101384601A Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics |
| 03/11/2009 | CN101384600A Crystalline forms of (3r,4r)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methol]piperidin-3-ol |
| 03/11/2009 | CN101384599A Heterocyclic antiviral compounds |
| 03/11/2009 | CN101384596A Heterocylic antiviral compounds |
| 03/11/2009 | CN101384595A Salt of CD 80 antagonist |
| 03/11/2009 | CN101384594A Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 03/11/2009 | CN101384593A 3-deazapurine derivatives as tlr7 modulators |
| 03/11/2009 | CN101384590A Oxazoloisoquinoline derivatives as thrombin receptor antagonists |
| 03/11/2009 | CN101384588A Process for preparing intermediates to 5-ht4 receptor agonist compounds |
| 03/11/2009 | CN101384587A Heterocyclic antiviral compounds |
| 03/11/2009 | CN101384586A Pi-3 kinase inhibitors and methods of their use |
| 03/11/2009 | CN101384585A Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders |
| 03/11/2009 | CN101384584A Crystal form of besipirdine chlorhydrate, process preparation and use thereof |
| 03/11/2009 | CN101384581A Benzoyl-piperidine derivatives as 5HT2/D3 modulators |
| 03/11/2009 | CN101384578A Radioligands for the 5 -ht1b receptor |
| 03/11/2009 | CN101384577A Novel coumarin derivative having antitumor activity |
| 03/11/2009 | CN101384576A Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture |
| 03/11/2009 | CN101384575A Tiglien-3-one derivatives |
| 03/11/2009 | CN101384568A Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 03/11/2009 | CN101384567A Diphenylurea derivatives and their use as chloride channel blockers or BKcA channel modulators |
| 03/11/2009 | CN101384565A Substituted oxadiazole derivatives and their use as opioid receptor ligands |
| 03/11/2009 | CN101384563A Substituted oxazole derivatives with an analgesic action |
| 03/11/2009 | CN101384558A Gaba-b receptor modulators |
| 03/11/2009 | CN101384557A Substituted imidazoline derivatives |
| 03/11/2009 | CN101384555A Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 03/11/2009 | CN101384554A Pyridine-2-carboxamide derivatives |
| 03/11/2009 | CN101384553A Substituted aniline derivatives useful as histamine h3 antagonists |
| 03/11/2009 | CN101384550A Amide derivative or salt thereof |
| 03/11/2009 | CN101384549A Pyrrole derivative or salt thereof |
| 03/11/2009 | CN101384540A Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 03/11/2009 | CN101384301A Proteasom or ups inhibitor for treating infections with influenza viruses |
| 03/11/2009 | CN101384268A Beta glycolipids as immuno-modulators |
| 03/11/2009 | CN101384267A Ibandronate regimen for treating metastatic bone pain |
| 03/11/2009 | CN101384266A Fixed-dose association of phytate and zinc |
| 03/11/2009 | CN101384265A Novel nutraceutical compositions and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 03/11/2009 | CN101384264A Therapeutic combinations comprising poly (adp-ribose) polymerases inhibitor |
| 03/11/2009 | CN101384263A Triazole compounds suitable for treating disorders that respond to modulaiont of the dopamine d3 receptor |
| 03/11/2009 | CN101384262A Use of pyrimidinedione derivative for preventing or treating hepatitis c |
| 03/11/2009 | CN101384261A Method and composition for treating pain |
| 03/11/2009 | CN101384260A Piperazine derivatives |
| 03/11/2009 | CN101384259A Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery |
| 03/11/2009 | CN101384258A FGF-peceptor agonist dimeric compounds |
| 03/11/2009 | CN101384257A Drug combinations |
| 03/11/2009 | CN101384256A Inhibitors of pai-1 for treatment of muscular conditions |
| 03/11/2009 | CN101384255A Bladder cancer treatment using e09 and propanediol |
| 03/11/2009 | CN101384254A Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases |
| 03/11/2009 | CN101384253A Disinfectant ointment |
| 03/11/2009 | CN101384251A Solid preparation containing an insulin sensitizer |
| 03/11/2009 | CN101384248A Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant |
| 03/11/2009 | CN101384246A External preparation for skin containing flavanone derivative |
| 03/11/2009 | CN101384241A Agent for promoting vitamin C transporter production |
| 03/11/2009 | CN101384172A Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 03/11/2009 | CN101381776A Method for detecting PPN/MG61 expression and use thereof |
| 03/11/2009 | CN101381725A Circular dumbbell decoy oligodeoxynucleotide (CDODN) containing transcription DNA binding sites |
| 03/11/2009 | CN101381418A Sterculia seed single polysaccharide SPA, preparation method and application thereof |
| 03/11/2009 | CN101381409A N-terminally chemically modified protein compositions and methods |
| 03/11/2009 | CN101381396A Pentacyclic triterpene saponins compounds, preparation method and use |
| 03/11/2009 | CN101381395A Pentacyclic triterpene saponins compounds, preparation method and use |
| 03/11/2009 | CN101381394A Pentacyclic triterpene saponins compounds, preparation method and use |
| 03/11/2009 | CN101381393A Pentacyclic triterpene saponins compounds, preparation method and use |
| 03/11/2009 | CN101381392A Pentacyclic triterpene saponins compounds, preparation method and use |
| 03/11/2009 | CN101381391A Triterpene saponins compounds extracted from ardipusilloside |
| 03/11/2009 | CN101381386A Lactose-azithromycin hydrate, preparation and use thereof |